Publication | Closed Access
Comparison of single dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache
67
Citations
0
References
1989
Year
Dhe GroupAcute PainPain MedicineEmergency Room PatientsPharmacotherapyVascular HeadachePain ManagementAnesthetic PharmacologyHealth SciencesCluster HeadacheMedicineSingle Dose MeperidinePostoperative Pain ManagementNeuropharmacologyPrimary Vascular HeadachePharmacologyPain ResearchAnesthesiaStrokeEmergency MedicineAnesthesiology
We treated 64 emergency room patients with a primary vascular headache with dihydroergotamine (DHE), meperidine, or butorphanol. Post-treatment pain scores were lowest in the DHE group (p less than 0.01). Eight of 21 patients receiving DHE had greater than 90% reduction in pain compared with three of 19 patients receiving butorphanol and none of 22 receiving meperidine.